Drug Discovery · South San Francisco, CA · Founded 2018 · Privately Held (backing)
Operator of a biotechnology company intended for the treatment of immunological diseases and cancer. Electra Therapeutics is based in South San Francisco, CA and was founded in 2018. It was valued at $479 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $301 million across 2 recorded rounds; the latest was an $183 million Series C in Oct 2025.
PMV mark · valuation
$479.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$301.0M
Last round
Later Stage VC (Series C)
Oct 2025
No prints on record
No secondary trades in Electra Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Electra Therapeutics with a free account
·The complete investor list: 14 names
·Watch Electra Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Electra Therapeutics stock.
